CARM Financial Statements

Balance sheet, income statement, cash flow, and dividends for Carisma Therapeutics Inc (CARM).


$17.48M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

CARM Market Cap. (MRY)


CARM Shares Outstanding (MRY)


CARM Assets (MRY)


Total Assets

$30.46M

Total Liabilities

$58.37M

Total Investments

$0

CARM Income (MRY)


Revenue

$19.63M

Net Income

-$60.48M

Operating Expense

$81.81M

CARM Cash Flow (MRY)


CF Operations

-$59.92M

CF Investing

-$123.00K

CF Financing

$344.00K

CARM Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0.36

12.30%

0%

-13.94%

-7.17

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

-

-

2020

$0

0%

-

0%

-

CARM Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$30,458,000 (-65.99%)

$89,554,000 (24.12%)

$72,153,000 (-70.03%)

$240,747,000 (96.01%)

Assets Current

$23,825,000 (-70.39%)

$80,471,000 (47.40%)

$54,592,000 (-73.45%)

$205,605,000 (227.05%)

Assets Non-Current

$6,633,000 (-26.97%)

$9,083,000 (-48.28%)

$17,561,000 (-50.03%)

$35,142,000 (-41.39%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$27,764,000 (-53.31%)

Shareholders Equity

-$27,909,000 (-205.19%)

$26,532,000 (116.89%)

-$157,065,000 (-191.47%)

$171,710,000 (1960.95%)

Property Plant & Equipment Net

$6,425,000 (-28.11%)

$8,937,000 (-33.55%)

$13,450,000 (31179.07%)

$43,000 (-65.04%)

Cash & Equivalents

$17,909,000 (-76.92%)

$77,605,000 (220.76%)

$24,194,000 (-85.12%)

$162,636,000 (193.63%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

-$41,000 (0%)

$0 (0%)

Deferred Revenue

$44,979,000 (-3.09%)

$46,413,000 (-2.20%)

$47,459,000 (3063.93%)

$1,500,000 (-50.00%)

Total Investments

$0 (0%)

$0 (0%)

$27,802,000 (138910.00%)

$20,000 (0.00%)

Investments Current

$0 (0%)

$0 (0%)

$27,802,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$20,000 (0.00%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$24,493,000 (0%)

Trade & Non-Trade Payables

$2,081,000 (-47.09%)

$3,933,000 (127.60%)

$1,728,000 (-39.43%)

$2,853,000 (-8.03%)

Accumulated Retained Earnings (Deficit)

-$305,579,000 (-24.67%)

-$245,102,000 (-54.91%)

-$158,223,000 (49.97%)

-$316,257,000 (-0.11%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$3,969,000 (-68.32%)

Total Debt

$2,481,000 (-20.56%)

$3,123,000 (-92.22%)

$40,164,000 (0%)

$0 (0%)

Debt Current

$1,737,000 (-10.23%)

$1,935,000 (-57.93%)

$4,599,000 (0%)

$0 (0%)

Debt Non-Current

$744,000 (-37.37%)

$1,188,000 (-96.66%)

$35,565,000 (0%)

$0 (0%)

Total Liabilities

$58,367,000 (-7.39%)

$63,022,000 (-41.11%)

$107,015,000 (55.01%)

$69,037,000 (-47.72%)

Liabilities Current

$16,055,000 (0.92%)

$15,908,000 (-19.13%)

$19,670,000 (70.04%)

$11,568,000 (-35.91%)

Liabilities Non-Current

$42,312,000 (-10.19%)

$47,114,000 (-46.06%)

$87,345,000 (51.99%)

$57,469,000 (-49.59%)

CARM Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$19,632,000 (31.59%)

$14,919,000 (-62.70%)

$40,000,000 (50.69%)

$26,544,000 (136.24%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$22,138,000 (-25.02%)

$29,525,000 (-25.79%)

$39,787,000 (35.36%)

$29,393,000 (105.52%)

Research & Development Expense

$59,673,000 (-19.50%)

$74,125,000 (92.06%)

$38,594,000 (52.47%)

$25,312,000 (-13.29%)

Operating Expenses

$81,811,000 (-21.07%)

$103,650,000 (-12.09%)

$117,909,000 (28.26%)

$91,933,000 (111.37%)

Interest Expense

$0 (0%)

-$1,936,000 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

-$3,875,000 (53.16%)

-$8,273,000 (-672.53%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$60,477,000 (30.39%)

-$86,879,000 (-336.93%)

-$19,884,000 (-5817.86%)

-$336,000 (98.50%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$60,477,000 (30.39%)

-$86,879,000 (-336.93%)

-$19,884,000 (-5817.86%)

-$336,000 (98.50%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$60,477,000 (30.39%)

-$86,879,000 (-336.93%)

-$19,884,000 (-5817.86%)

-$336,000 (98.51%)

Weighted Average Shares

$41,456,210 (23.66%)

$33,524,197 (234.33%)

$10,027,300 (9.99%)

$9,116,150 (54.22%)

Weighted Average Shares Diluted

$41,456,210 (23.66%)

$33,524,197 (234.33%)

$10,027,300 (9.99%)

$9,116,150 (54.22%)

Earning Before Interest & Taxes (EBIT)

-$60,477,000 (31.91%)

-$88,815,000 (-273.82%)

-$23,759,000 (-175.98%)

-$8,609,000 (58.91%)

Gross Profit

$19,632,000 (31.59%)

$14,919,000 (-62.70%)

$40,000,000 (50.69%)

$26,544,000 (136.24%)

Operating Income

-$62,179,000 (29.92%)

-$88,731,000 (-13.89%)

-$77,909,000 (-19.15%)

-$65,389,000 (-102.71%)

CARM Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$123,000 (-100.17%)

$72,408,000 (234.17%)

-$53,969,000 (-1349125.00%)

-$4,000 (50.00%)

Net Cash Flow from Financing

$344,000 (-99.45%)

$62,180,000 (6217900.00%)

$1,000 (-100.00%)

$176,129,000 (362.12%)

Net Cash Flow from Operations

-$59,917,000 (26.19%)

-$81,177,000 (-426.08%)

$24,895,000 (136.14%)

-$68,878,000 (-123.36%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$59,696,000 (-211.77%)

$53,411,000 (283.71%)

-$29,073,000 (-127.11%)

$107,247,000 (1375.61%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$73,540,000 (236.19%)

-$53,999,000 (0%)

$0 (0%)

Capital Expenditure

-$123,000 (89.13%)

-$1,132,000 (-3873.33%)

$30,000 (850.00%)

-$4,000 (50.00%)

Issuance (Repayment) of Debt Securities

-$2,052,000 (-53.94%)

-$1,333,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$2,396,000 (-92.38%)

$31,424,000 (3142300.00%)

$1,000 (-100.00%)

$176,130,000 (362.26%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$3,649,000 (57.56%)

$2,316,000 (-66.48%)

$6,909,000 (34.34%)

$5,143,000 (192.71%)

Depreciation Amortization & Accretion

$8,317,000 (0.63%)

$8,265,000 (63476.92%)

$13,000 (-84.71%)

$85,000 (-30.33%)

CARM Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-308.10% (47.09%)

-582.30% (-1071.63%)

-49.70% (-3723.08%)

-1.30% (99.35%)

EBITDA Margin

-265.70% (50.79%)

-539.90% (-808.92%)

-59.40% (-85.05%)

-32.10% (82.69%)

Return on Average Equity (ROAE)

870.80% (665.45%)

-154.00% (-526.02%)

-24.60% (-8100.00%)

-0.30% (-100.03%)

Return on Average Assets (ROAA)

-117.60% (-64.25%)

-71.60% (-506.78%)

-11.80% (-11700.00%)

-0.10% (99.51%)

Return on Sales (ROS)

-308.10% (48.24%)

-595.30% (-902.19%)

-59.40% (-83.33%)

-32.40% (82.63%)

Return on Invested Capital (ROIC)

-942.70% (-255.07%)

-265.50% (-609.89%)

-37.40% (23.83%)

-49.10% (-111.36%)

Dividend Yield

0% (0%)

12.30% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.29 (74.62%)

-1.13 (81.44%)

-6.09

-

Price to Sales Ratio (P/S)

0.88 (-86.57%)

6.58 (115.45%)

3.06 (-45.41%)

5.6 (-60.59%)

Price to Book Ratio (P/B)

-0.63 (-114.05%)

4.46 (666.33%)

-0.79 (-183.10%)

0.95 (105.00%)

Debt to Equity Ratio (D/E)

-2.09 (-188.04%)

2.38 (448.75%)

-0.68 (-269.40%)

0.4 (102.81%)

Earnings Per Share (EPS)

-1.46 (43.63%)

-2.59 (-29.50%)

-2 (0%)

0 (0%)

Sales Per Share (SPS)

0.47 (6.52%)

0.45 (-88.84%)

3.99 (36.98%)

2.91 (53.18%)

Free Cash Flow Per Share (FCFPS)

-1.45 (41.02%)

-2.46 (-198.75%)

2.49 (132.90%)

-7.56 (-44.81%)

Book Value Per Share (BVPS)

-0.67 (-185.08%)

0.79 (105.05%)

-15.66 (-183.16%)

18.84 (1306.66%)

Tangible Assets Book Value Per Share (TABVPS)

0.73 (-72.48%)

2.67 (-62.88%)

7.2 (-69.20%)

23.36 (117.96%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-2 (-300.00%)

1 (116.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.12 (124.89%)

-0.47 (78.73%)

-2.21 (-248.62%)

1.49 (123.35%)

Asset Turnover

0.38 (210.57%)

0.12 (-48.10%)

0.24 (102.56%)

0.12 (13.59%)

Current Ratio

1.48 (-70.67%)

5.06 (82.31%)

2.77 (-84.39%)

17.77 (410.31%)

Dividends

$0 (0%)

$0.36 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$60,040,000 (27.06%)

-$82,309,000 (-430.23%)

$24,925,000 (136.19%)

-$68,882,000 (-123.32%)

Enterprise Value (EV)

-$6,079,054 (-116.07%)

$37,830,442 (-27.91%)

$52,473,399 (514.05%)

-$12,673,129 (-109.56%)

Earnings Before Tax (EBT)

-$60,477,000 (30.39%)

-$86,879,000 (-265.67%)

-$23,759,000 (-175.98%)

-$8,609,000 (58.91%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$52,160,000 (35.25%)

-$80,550,000 (-239.22%)

-$23,746,000 (-178.58%)

-$8,524,000 (59.08%)

Invested Capital

-$1,025,000 (-22.61%)

-$836,000 (-101.22%)

$68,453,000 (76.52%)

$38,779,000 (484.75%)

Working Capital

$7,770,000 (-87.97%)

$64,563,000 (84.88%)

$34,922,000 (-82.00%)

$194,037,000 (332.94%)

Tangible Asset Value

$30,458,000 (-65.99%)

$89,554,000 (24.12%)

$72,153,000 (-66.12%)

$212,983,000 (236.15%)

Market Capitalization

$17,484,946 (-85.21%)

$118,245,442 (-4.32%)

$123,580,399 (-23.98%)

$162,562,871 (-6.90%)

Average Equity

-$6,945,000 (-112.31%)

$56,401,250 (-30.18%)

$80,779,750 (-17.43%)

$97,834,250 (4030.27%)

Average Assets

$51,412,500 (-57.64%)

$121,370,750 (-27.96%)

$168,470,000 (-25.45%)

$225,969,750 (106.49%)

Invested Capital Average

$6,415,250 (-80.82%)

$33,446,750 (-47.38%)

$63,563,750 (262.32%)

$17,543,500 (462.00%)

Shares

41,750,109 (3.45%)

40,356,806 (298.08%)

10,137,851 (1.65%)

9,973,182 (54.22%)